English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/213249
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Osteogenic effect of local, long versus short term BMP-2 delivery from a novel SPU–PLGA–βTCP concentric system in a critical size defect in rats

AuthorsRodríguez-Évora, María; Delgado, Araceli; Reyes, Ricardo; Hernández Daranas, Antonio ; Soriano, Isabel; San Román, J.; Évora, Carmen
KeywordsBone regeneration
BMP-2
Sustained delivery
SPU–PLGA–βTCP system
In vivo degradation
Issue Date16-Aug-2013
PublisherElsevier
CitationEuropean Journal of Pharmaceutical Sciences 49(5): 873-884 (2013)
AbstractA concentric delivery system, composed of the three biomaterials SPU, PLGA, and βTCP (segmented polyurethane, poly[lactic-co-glycolic acid], and β-tricalcium phosphate) was fabricated as an external, porous ring of βTCP with a pasty core of a new SPU, mixed with PLGA microspheres. The regenerative effects of two distinct doses of either immediately available or continuously released rhBMP-2 were evaluated in an 8 mm, critical calvaria defect in rats. Protein dose and release kinetics affected material resorption rates and the progression of the regeneration process. Groups treated with the empty system alone or in conjunction with free rhBMP-2 did not respond. By contrast, after 12 weeks, approximately 20% and 60% of the defects implanted with systems loaded with 1.6 μg and 6.5 μg rhBMP-2, respectively were healed, with all the growth factor being released in the course of 6 weeks. The NMR, FTIR, GPC, DSC, and histological analyses showed that PLGA microsphere degradation occurred independently of the regenerative process. However, the resorption rate of the SPU and βTCP did depend on the regeneration process, which was governed by dose and release rate of rhBMP-2. Furthermore, the biocompatibility and high capacity of adaptation to the defect convert the herein proposed, new SPU polymer into a potential material for applications in tissue engineering and regenerative medicine.
Publisher version (URL)https://doi.org/10.1016/j.ejps.2013.06.008
URIhttp://hdl.handle.net/10261/213249
DOIhttp://dx.doi.org/10.1016/j.ejps.2013.06.008
ISSN0928-0987
E-ISSN1879-0720
Appears in Collections:(IPNA) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdfArtículo principal16,34 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.